Get notified when NEO files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsNeoGenomics adds former Flatiron Health CEO Carolyn Starrett to Board
Filed June 25, 2026 · Period ending June 23, 2026 · ~1 min read
Key Changes
-
medium
Board expanded from nine to ten directors with appointment of Carolyn Starrett, former Flatiron Health CEO (2021-2025), effective June 23, 2026. She will serve until the 2027 annual meeting.
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR → -
medium
Starrett brings 25+ years in data and technology companies with deep expertise in AI and data insights for cancer care. She spent a decade at Flatiron Health in executive roles and served on Foundation Medicine's board (2021-2024).
Exhibit 99.1 verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (CNTA 8-K) is open in full — no account needed.
Partner
Trade NEO commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 25, 2026 11:06 AM